Alkeon Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $87.9M | Hold |
|
|||||
|
2025
Q2 | $98.8M | Buy |
|
|||||
|
2025
Q1 | $62.8M | Sell |
|
|||||
|
2024
Q4 | $49M | Sell |
|
|||||
|
2024
Q3 | $95.4M | Sell |
|
|||||
|
2024
Q2 | $78.1M | Hold |
|
|||||
|
2024
Q1 | $84M | Sell |
|
|||||
|
2023
Q4 | $87.9M | Sell |
|
|||||
|
2023
Q3 | $191M | Buy |
|
|||||
|
2023
Q2 | $162M | Buy |
|
|||||
|
2023
Q1 | $123M | Sell |
|
|||||
|
2022
Q4 | $178M | Buy |
|
|||||
|
2022
Q3 | $108M | Buy |
|
|||||
|
2022
Q2 | $24.8M | Buy |
|
|||||
|
2022
Q1 | $34.3M | Sell |
|
|||||
|
2021
Q4 | $52.4M | Hold |
|
|||||
|
2021
Q3 | $55.4M | Sell |
|
|||||
|
2021
Q2 | $61.8M | Sell |
|
|||||
|
2021
Q1 | $72.4M | Buy |
|
|||||
|
2020
Q4 | $59M | Buy |
|
|||||
|
2020
Q3 | $70.2M | Buy |
|
|||||
|
2020
Q2 | $24.9M | Buy |
|
|||||
|
2020
Q1 | $19.6M | Buy |
|
|||||
|
2019
Q4 | $9.76M | Sell |
|
|||||
|
2019
Q3 | $11.4M | Buy |
|
|||||
|
2019
Q2 | $4.23M | Buy |
|